tirzepatide indications fda Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ Is Tirzepatide FDA Approved?

Monjauro Mounjaro, FDA-approved in 2022 for the treatment of type 2 diabetes, is one of Eli Lillys most widely discussed drugs due to its reported weight loss benefits

For example, caregivers combine it with meds such as ipratropium bromide

A realistic UK timeline One UK-focused source states that the earliest realistic MHRA approval is late 2027 to mid-2028, with NHS access from 2029 at the earliest (Second Nature's UK guide to buying retatrutide online)

Evidence quality assessment Strong evidence: BPC-157 accelerates tendon healing in rats (multiple independent studies, consistent results, large effect sizes)

Can I get these medications just for weight loss, or only for diabetes